HANAN HUSSEIN: Open Payments
NPI 1871786566 · LEAGUE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,047 in 111 payments from 30 companies in 2025. Trend: 2023 $2,213 · 2024 $2,551 · 2025 $2,047
Food & beverage: $2,047
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $287 |
| Novo Nordisk Inc | 11 | $221 |
| ABBVIE INC. | 14 | $186 |
| Amgen Inc. | 9 | $141 |
| GlaxoSmithKline, LLC. | 7 | $119 |
| PFIZER INC. | 5 | $114 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Exact Sciences Corporation | 4 | $66 |
| Corium, LLC | 8 | $64 |
Products named: AIRSUPRA, Wegovy, OTEZLA, TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, Auvelity, UBRELVY.
Industry payments across TX — which companies pay providers there.
